COVID-19 Impact on Global Addison's Disease Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 94 pages | ID: C445A08AAF30EN
QYResearch

Abstracts

This report focuses on the global Addison's Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Addison's Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• GlaxoSmithKline
• Takeda
• Abbott Laboratories
• Merck
• Boehringer Ingelheim
• Amgen
• Lupin Pharmaceuticals

Market segment by Type, the product can be split into

• Oral Corticosteroid
• Corticosteroid Injections

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Addison's Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Addison's Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Addison's Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Addison's Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Addison's Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral Corticosteroid
  1.4.3 Corticosteroid Injections
1.5 Market by Application
  1.5.1 Global Addison's Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Addison's Disease Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Addison's Disease Treatment Industry
    1.6.1.1 Addison's Disease Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Addison's Disease Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Addison's Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Addison's Disease Treatment Market Perspective (2015-2026)
2.2 Addison's Disease Treatment Growth Trends by Regions
  2.2.1 Addison's Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Addison's Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Addison's Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Addison's Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Addison's Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Addison's Disease Treatment Players by Market Size
  3.1.1 Global Top Addison's Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Addison's Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Addison's Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Addison's Disease Treatment Market Concentration Ratio
  3.2.1 Global Addison's Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Addison's Disease Treatment Revenue in 2019
3.3 Addison's Disease Treatment Key Players Head office and Area Served
3.4 Key Players Addison's Disease Treatment Product Solution and Service
3.5 Date of Enter into Addison's Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Addison's Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Addison's Disease Treatment Forecasted Market Size by Type (2021-2026)

5 ADDISON'S DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Addison's Disease Treatment Market Size by Application (2015-2020)
5.2 Global Addison's Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Addison's Disease Treatment Market Size (2015-2020)
6.2 Addison's Disease Treatment Key Players in North America (2019-2020)
6.3 North America Addison's Disease Treatment Market Size by Type (2015-2020)
6.4 North America Addison's Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Addison's Disease Treatment Market Size (2015-2020)
7.2 Addison's Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Addison's Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Addison's Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Addison's Disease Treatment Market Size (2015-2020)
8.2 Addison's Disease Treatment Key Players in China (2019-2020)
8.3 China Addison's Disease Treatment Market Size by Type (2015-2020)
8.4 China Addison's Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Addison's Disease Treatment Market Size (2015-2020)
9.2 Addison's Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Addison's Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Addison's Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Addison's Disease Treatment Market Size (2015-2020)
10.2 Addison's Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Addison's Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Addison's Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Addison's Disease Treatment Market Size (2015-2020)
11.2 Addison's Disease Treatment Key Players in India (2019-2020)
11.3 India Addison's Disease Treatment Market Size by Type (2015-2020)
11.4 India Addison's Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Addison's Disease Treatment Market Size (2015-2020)
12.2 Addison's Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Addison's Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Addison's Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Addison's Disease Treatment Introduction
  13.1.4 Pfizer Revenue in Addison's Disease Treatment Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Details
  13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Addison's Disease Treatment Introduction
  13.2.4 GlaxoSmithKline Revenue in Addison's Disease Treatment Business (2015-2020)
  13.2.5 GlaxoSmithKline Recent Development
13.3 Takeda
  13.3.1 Takeda Company Details
  13.3.2 Takeda Business Overview and Its Total Revenue
  13.3.3 Takeda Addison's Disease Treatment Introduction
  13.3.4 Takeda Revenue in Addison's Disease Treatment Business (2015-2020)
  13.3.5 Takeda Recent Development
13.4 Abbott Laboratories
  13.4.1 Abbott Laboratories Company Details
  13.4.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.4.3 Abbott Laboratories Addison's Disease Treatment Introduction
  13.4.4 Abbott Laboratories Revenue in Addison's Disease Treatment Business (2015-2020)
  13.4.5 Abbott Laboratories Recent Development
13.5 Merck
  13.5.1 Merck Company Details
  13.5.2 Merck Business Overview and Its Total Revenue
  13.5.3 Merck Addison's Disease Treatment Introduction
  13.5.4 Merck Revenue in Addison's Disease Treatment Business (2015-2020)
  13.5.5 Merck Recent Development
13.6 Boehringer Ingelheim
  13.6.1 Boehringer Ingelheim Company Details
  13.6.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.6.3 Boehringer Ingelheim Addison's Disease Treatment Introduction
  13.6.4 Boehringer Ingelheim Revenue in Addison's Disease Treatment Business (2015-2020)
  13.6.5 Boehringer Ingelheim Recent Development
13.7 Amgen
  13.7.1 Amgen Company Details
  13.7.2 Amgen Business Overview and Its Total Revenue
  13.7.3 Amgen Addison's Disease Treatment Introduction
  13.7.4 Amgen Revenue in Addison's Disease Treatment Business (2015-2020)
  13.7.5 Amgen Recent Development
13.8 Lupin Pharmaceuticals
  13.8.1 Lupin Pharmaceuticals Company Details
  13.8.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Lupin Pharmaceuticals Addison's Disease Treatment Introduction
  13.8.4 Lupin Pharmaceuticals Revenue in Addison's Disease Treatment Business (2015-2020)
  13.8.5 Lupin Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Addison's Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Addison's Disease Treatment Revenue
Table 3. Ranking of Global Top Addison's Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Addison's Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Corticosteroid
Table 6. Key Players of Corticosteroid Injections
Table 7. COVID-19 Impact Global Market: (Four Addison's Disease Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Addison's Disease Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Addison's Disease Treatment Players to Combat Covid-19 Impact
Table 12. Global Addison's Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Addison's Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Addison's Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Addison's Disease Treatment Market Share by Regions (2015-2020)
Table 16. Global Addison's Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Addison's Disease Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Addison's Disease Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Addison's Disease Treatment Players
Table 23. Global Addison's Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Addison's Disease Treatment Market Share by Players (2015-2020)
Table 25. Global Top Addison's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addison's Disease Treatment as of 2019)
Table 26. Global Addison's Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Addison's Disease Treatment Product Solution and Service
Table 29. Date of Enter into Addison's Disease Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Addison's Disease Treatment Market Size Share by Type (2015-2020)
Table 33. Global Addison's Disease Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Addison's Disease Treatment Market Size Share by Application (2015-2020)
Table 35. Global Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Addison's Disease Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Addison's Disease Treatment Market Share (2019-2020)
Table 39. North America Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Addison's Disease Treatment Market Share by Type (2015-2020)
Table 41. North America Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Addison's Disease Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Addison's Disease Treatment Market Share (2019-2020)
Table 45. Europe Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Addison's Disease Treatment Market Share by Type (2015-2020)
Table 47. Europe Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Addison's Disease Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Addison's Disease Treatment Market Share (2019-2020)
Table 51. China Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Addison's Disease Treatment Market Share by Type (2015-2020)
Table 53. China Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Addison's Disease Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Addison's Disease Treatment Market Share (2019-2020)
Table 57. Japan Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Addison's Disease Treatment Market Share by Type (2015-2020)
Table 59. Japan Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Addison's Disease Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Addison's Disease Treatment Market Share (2019-2020)
Table 63. Southeast Asia Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Addison's Disease Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Addison's Disease Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Addison's Disease Treatment Market Share (2019-2020)
Table 69. India Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Addison's Disease Treatment Market Share by Type (2015-2020)
Table 71. India Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Addison's Disease Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Addison's Disease Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Addison's Disease Treatment Market Share (2019-2020)
Table 75. Central & South America Addison's Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Addison's Disease Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Addison's Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Addison's Disease Treatment Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Product
Table 87. GlaxoSmithKline Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 88. GlaxoSmithKline Recent Development
Table 89. Takeda Company Details
Table 90. Takeda Business Overview
Table 91. Takeda Product
Table 92. Takeda Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 93. Takeda Recent Development
Table 94. Abbott Laboratories Company Details
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Product
Table 97. Abbott Laboratories Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 98. Abbott Laboratories Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Product
Table 102. Merck Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 103. Merck Recent Development
Table 104. Boehringer Ingelheim Company Details
Table 105. Boehringer Ingelheim Business Overview
Table 106. Boehringer Ingelheim Product
Table 107. Boehringer Ingelheim Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 108. Boehringer Ingelheim Recent Development
Table 109. Amgen Company Details
Table 110. Amgen Business Overview
Table 111. Amgen Product
Table 112. Amgen Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 113. Amgen Recent Development
Table 114. Lupin Pharmaceuticals Business Overview
Table 115. Lupin Pharmaceuticals Product
Table 116. Lupin Pharmaceuticals Company Details
Table 117. Lupin Pharmaceuticals Revenue in Addison's Disease Treatment Business (2015-2020) (Million US$)
Table 118. Lupin Pharmaceuticals Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Addison's Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Corticosteroid Features
Figure 3. Corticosteroid Injections Features
Figure 4. Global Addison's Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Addison's Disease Treatment Report Years Considered
Figure 9. Global Addison's Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Addison's Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Addison's Disease Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Addison's Disease Treatment Market Share by Players in 2019
Figure 14. Global Top Addison's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addison's Disease Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Addison's Disease Treatment Revenue in 2019
Figure 16. North America Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Addison's Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 25. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. GlaxoSmithKline Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 29. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Abbott Laboratories Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 33. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Boehringer Ingelheim Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 35. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Amgen Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 37. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Lupin Pharmaceuticals Revenue Growth Rate in Addison's Disease Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed